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ttp://dx.doi.org/10.1016/j.ajpath.2014.10.005Ehrlichia species are intracellular bacteria that cause fatal ehrlichiosis, mimicking toxic shock syndrome
in humans and mice. Virulent ehrlichiae induce inﬂammasome activation leading to caspase-1 cleavage
and IL-18 secretion, which contribute to development of fatal ehrlichiosis. We show that fatal infection
triggers expression of inﬂammasome components, activates caspase-1 and caspase-11, and induces
host-cell death and secretion of IL-1b, IL-1a, and type I interferon (IFN-I). Wild-type and Casp1/
mice were highly susceptible to fatal ehrlichiosis, had overwhelming infection, and developed extensive
tissue injury. Nlrp3/ mice effectively cleared ehrlichiae, but displayed acute mortality and developed
liver injury similar to wild-type mice. By contrast, Ifnar1/ mice were highly resistant to fatal disease
and had lower bacterial burden, attenuated pathology, and prolonged survival. Ifnar1/ mice also had
improved protective immune responses mediated by IFN-g and CD4þ Th1 and natural killer T cells, with
lower IL-10 secretion by T cells. Importantly, heightened resistance of Ifnar1/ mice correlated with
improved autophagosome processing, and attenuated noncanonical inﬂammasome activation indicated
by decreased activation of caspase-11 and decreased IL-1b, compared with other groups. Our ﬁndings
demonstrate that IFN-I signaling promotes host susceptibility to fatal ehrlichiosis, because it mediates
ehrlichia-induced immunopathology and supports bacterial replication, perhaps via activation of
noncanonical inﬂammasomes, reduced autophagy, and suppression of protective CD4þ T cells and
natural killer T-cell responses against ehrlichiae. (Am J Pathol 2015, 185: 446e461; http://dx.doi.org/
10.1016/j.ajpath.2014.10.005)Supported by NIH grants R56-AI097679-01A (N.I.) and R01-
GM102146 (M.J.S.).
Disclosures: None declared.Ehrlichia chaffeensis is the causative agent of human
monocytotropic ehrlichiosis, a highly prevalent life-
threatening tickborne disease in North America.1e3 Central
to the pathogenesis of human monocytotropic ehrlichiosis is
the ability of ehrlichiae to survive and replicate inside the
phagosomal compartment of host macrophages and to
secrete proteins via type I and type IV secretion systems into
the host-cell cytosol.4 Using murine models of ehrlichiosis,
we and others have demonstrated that fatal ehrlichial infec-
tion is associated with severe tissue damage caused by
TNF-aeproducing cytotoxic CD8þ T cells (ie, immunopa-
thology) and the suppression of protective CD4þ Th1
immune responses.5e14 However, neither how the Ehrlichia
bacteria trigger innate immune responses nor how thesestigative Pathology.
.responses inﬂuence the acquired immunity against ehrlichiae
is entirely known.
Extracellular and intracellular pattern recognition receptors
recognize microbial infections.15e18 Recently, members of
the cytosolic nucleotide-binding domain and leucine-rich
repeat family (NLRs; alias NOD-like receptors), such as
NLRP3, have emerged as critical pattern recognition
receptors in the host defense against intracellular pathogens.
NLRs recognize intracellular bacteria and trigger innate,
protective immune responses.19e23 NLRs respond to both
Type I IFN in Fatal Ehrlichiosismicrobial products and endogenous host danger signals to
form multimeric protein platforms known as inﬂammasomes.
The NLRP3 inﬂammasome consists of multimers of NLRP3
that bind to the adaptor molecules and apoptosis-associated
speck-like protein (ASC) to recruit proecaspase-1 and facili-
tate cleavage and activation of caspase-1.15,16,24 The canonical
inﬂammasome pathway involves the cleavage of immature
forms of IL-1b and IL-18 (proeIL-1b and proeIL-18) into
biologically active mature IL-1b and IL-18 by active caspase-
1.25e28 The noncanonical inﬂammasome pathway marked by
the activation of caspase-11 has been described recently.
Active caspase-11 promotes the caspase-1edependent secre-
tion of IL-1b/IL-18 and mediates inﬂammatory lytic host-cell
death via pyroptosis, a process associated with the secretion of
IL-1a and HMGB1.17,29e31 Several key regulatory check-
points ensure the proper regulation of inﬂammasome activa-
tion.16,32 For example, blocking autophagy by the genetic
deletion of the autophagy regulatory protein ATG16L1
increases the sensitivity of macrophages to the inﬂammasome
activation induced by TLRs.33 Furthermore, TIR domain-
containing adaptor molecule 1 (TICAM-1; alias TRIF) has
been linked to inﬂammasome activation via the secretion of
type I interferons a and b (IFN-a and IFN-b) and the acti-
vation of caspase-11 during infections with Gram-negative
bacteria.2,34e39
We have recently demonstrated that fatal ehrlichial
infection induces excess IL-1b and IL-18 production,
compared with mild infection,8,12e14 and that lack of IL-18
signaling enhances resistance of mice to fatal ehrlichio-
sis.12 These ﬁndings suggest that inﬂammasomes play a
detrimental role in the host defense against ehrlichial
infection. Elevated production of IL-1b and IL-18 in fatal
ehrlichiosis was associated with an increase in hepatic
expression of IFN-a.14 IFN-I plays a critical role in the
host defense against viral and speciﬁc bacterial
infections.28,36,37,40e43 However, the mechanism by which
type I IFN contributes to fatal ehrlichial infection remains
unknown. Our present results reveal, for the ﬁrst time, that
IFNAR1 promotes detrimental inﬂammasome activation,
mediates immunopathology, and impairs protective immunity
against ehrlichiae via mechanisms that involve caspase-11
activation, blocking of autophagy, and production of IL-10.
Our novel ﬁnding that lipopolysaccharide (LPS)-negative
ehrlichiae trigger IFNAR1-dependent caspase-11 activation
challenges the current paradigm that implicates LPS as the
major microbial ligand triggering the noncanonical inﬂam-
masome pathway during Gram-negative bacterial infection.
Materials and Methods
Mice and Ehrlichial Infection in Vivo
The following mice, aged 8 to 12 weeks, were used: wild-
type (WT) C57BL/6 (B6) (Jackson Laboratory, Bar Harbor,
ME); Nlrp3/ (NLR family, pyrin domain containing 3)
(Millennium Pharmaceuticals, Boston, MA); Casp1/The American Journal of Pathology - ajp.amjpathol.org(a gift from Richard Flavell, Yale University, New Haven,
CT)44; and Ifnar1/ (B6.129S2-Ifnar1tm1Agt/Mmjax; Mutant
Mouse Regional Resource CentereJackson Laboratory). All
animals were housed under speciﬁc pathogenefree condi-
tions at the University of Pittsburgh in accordance with
institutional guidelines for animal welfare.
The highly virulent monocytotropic Ixodes ovatus ehrlichia
(IOE) strain, provided by Dr. Yasuko Rikihisa (Ohio State
University, Columbus, OH) was used. The IOE stock was
propagated by passage throughWT C57BL/6 mice. Single-cell
suspensions from spleen of IOE-infected mice were collected
on day 7 after infection (day 7 p.i.) and stored in liquid nitrogen
for use as stocks. The mice were infected intraperitoneally with
1 mL of splenocytes containing approximately 103 IOE
bacterial genomes per mouse. Mice were monitored daily for
signs of illness and survival. At speciﬁed time points, three to
ﬁve mice per experimental group were sacriﬁced, and the
selected organs were harvested for further analysis.
Histology
Formalin-ﬁxed, parafﬁn-embedded samples from the right
lobe of the liver were collected on day 7 p.i. from each mouse
group (before perfusion with phosphate-buffered saline) and
then were sectioned and stained with hematoxylin and eosin.
Histological sections were evaluated qualitatively for
morphological differences and quantitatively for apoptosis
(by TUNEL immunohistochemical assays). TUNEL staining
(Research Histology Services, University of Pittsburgh) was
performed on the formalin-ﬁxed, parafﬁn-embedded tissue
sections. Apoptotic Kupffer cells and hepatocytes were
counted in 10 high-power ﬁelds for each mouse. Stained
slides were viewed under an Olympus (Tokyo, Japan) BX40
microscope and were scanned using a Mirax MIDI slide
scanner (Carl Zeiss Microscopy, Jena, Germany); images
were captured using Pannoramic Viewer software (3DHis-
tech, Budapest, Hungary).
Isolation of Liver Mononuclear Cells
Primary hepatocytes were isolated from the liver of mice
according to the magnetic-activated cell sorting protocol
(MACS; Miltenyi Biotec, Auburn, CA) for preparation of
single-cell suspensions from mouse liver. In brief, the mouse
liver was perfused in situ with cold phosphate-buffered saline
via the portal vein. The liver tissuewas homogenized using the
Miltenyi Biotec gentleMACS program for liver, and the
samples were incubated at room temperature for 45 minutes
under slow continuous rotation. The resulting homogenate
was passed through a 100-mm cell strainer (BD Biosciences,
San Jose, CA) and centrifuged at 20  g for 4 minutes to
remove contaminating hepatocytes. After washing of cells and
lysis of red blood cells, the cells were resuspended in complete
medium (RPMI 1640 medium supplemented with 10% heat-
inactivated fetal bovine serum, 1% HEPES buffer, and
100 mg/mL penicillin and streptomycin) (Gibco; Life447
Yang et alTechnologies, Carlsbad, CA) and counted by trypan blue
exclusion to examine viability before use for ﬂow cytometry.
Flow Cytometry and Intracellular Cytokine Staining
Liver mononuclear cells and splenocytes were resuspended in
staining buffer for ﬂuorescence-activated cell sorting at a
concentration of 106 cells per well. FcRs were blocked with a
monoclonal antibody (clone 2.4G2) against mouse cell surface
antigens CD16 and CD32 for 15 minutes. Antibodies were
conjugated with ﬂuorescein isothiocyanate, phycoerythrin,
PerCPeCy5.5, Alexa Fluor 488 dye, or allophycocyanin. The
following antibodies were purchased from either BD
Biosciences or BioLegend (San Diego, CA; antibodies were
used at the concentrations recommended by the manufacturer):
anti-CD3 (clone 145-2C11), anti-CD11c (clone HL3), anti-
CD4 (clone RM4-4), anti-CD8a (clone 53-6.7), anti-CD25
(clone PC61), anti-CD11b (clone M1/70), anti-NK1.1 (clone
PK136), anti-B220 (clone RA3-6B2), antieIL-10 (clone
JES5-16E3), antieIFN-g (clone XMG102), anti-Ly6G (clone
1A8), antiegranzyme B (clone NGZB). Antiea-Gal-
Cereloaded CD1d tetramer was a gift from Dr. Luc Van Kaer
(Vanderbilt University, Nashville, TN). Isotype control
monoclonal antibodies were ﬂuorescein isothiocyanatee,
phycoerythrine, or allophycocyanin-conjugated hamster IgG1
(A19-3), rat IgG1 (R3-34), rat IgG2a (R35-95), mouse IgG2a
(X39), mouse IgG2b (MPC-11), mouse IgG1 (X40), and rat
IgG2b (A95-1). For intracellular cytokine staining, the sple-
nocytes were incubated with BD GolgiPlug (BD Biosciences).
Lymphocyte and granulocyte populations were gated based on
forward and side-scatter parameters. Approximately 50,000
events for spleen cells and 100,000 events for liver mono-
nuclear cells were collected using BD-LSR and BD FACS-
Calibur (Immunocytometry Systems; BD Biosciences) ﬂow
cytometry. Data were analyzed using FlowJo software version
7.5.5 (TreeStar, Ashland, OR).
Measurement of Cytokine Levels by Enzyme-Linked
Immunosorbent Assay
Spleens were harvested and single-cell suspensions were
prepared as described previously.5e8 Splenocytes (2  106 to
5  106) were seeded into 12-well culture plates in complete
medium in the presence or absence of IOE antigens. Culture
supernatants were collected after 24 or 48 hours. Concentra-
tion of IL-1b, IL-10, and IFN-g in supernatant and serum was
determined using a murine enzyme-linked immunosorbent
assay kit (eBioscience, San Diego, CA; Vienna, Austria)
according to the manufacturer’s recommendations. The mini-
mum detectable concentrations of IL-1b, IL-10, and IFN-g
were 1.2 pg/mL, 5 pg/mL, and 5.3 pg/mL, respectively.
Analysis of Bacterial Burden by Quantitative Real-Time
PCR
Relative differences in bacterial burden were measured by
quantitative real-time PCR using an iCycler IQ multicolor448real-time detection system (Bio-Rad Laboratories, Hercules,
CA) and primers and probes for the ehrlichia dsb gene and
Gapdh, as described previously.6,9 The ehrlichia primer and
probe sets used were EM/IOE dsb forward, 50-CAGGAT-
GGTAAAGTACGTGTGA-30; EM/IOE dsb reverse, 50-TAG-
CTAAYGCTGCCTGGACA-30; EM/IOE probe: (6FAM)-
AGGGATTTCCCTATACTCGGTGAGGC-(MGB-BHQ).
The eukaryotic housekeeping gene Gapdh was ampliﬁed
using the following primer and probe set: GAPDH for-
ward, 50-CAACTACATGGTCTACATGTTC-30; GAPDH
reverse, 50-TCGCTCCTGGAAGATG-30; GAPDH probe:
(6FAM)-CGGCACAGTCAAGGCCGAGAATGGGAAGC-
(MGB-BHQ). Results were normalized to the levels of the
Gapdh gene in the same samples. The comparative cycle
threshold (CT) method was used to determine the relative
differences in bacterial burden among groups of mice,
because we could not determine the number of cells present
in each sample. The results were considered negative for
ehrlichia DNA if CT  40 in the PCR reaction.
RT-PCR and Quantitative Real-Time PCR Analysis of
Host Genes
The mRNA from the liver samples was extracted using TRIzol
reagent (Invitrogen; Life Technologies), and the cDNA was
synthesized using an SA Biosciences reverse transcriptase
(RT)2 ﬁrst-strand kit (Qiagen, Valencia, CA). The expression
of IFN-I, caspase-1 and IL-1b mRNA was measured using the
following primers: mIFN-a forward, 50-AGGACAGGAAG-
GACTTCGGA-30 (20 bp); mIFN-a reverse, 50-GAGAGGTG-
CAGTGTCCTAGT-30 (20 bp); caspase-1 forward, 50-ATCA-
TTTCCGCGGTTGAAT-30 (19 bp); caspase-1 reverse,
50-AATTGCTGTGTGCGCATGT-30 (19 bp); IL-1b forward,
50-ACCCTGCAGTGGTTCGAG-30 (18 bp); IL-1b reverse,
50-TTGCACAAGGAAGCTTGG-30 (18 bp); GAPDH for-
ward, 50-AAATGAGAGAGGCCCAGCTA-30 (20 bp); and
GAPDH reverse, 50-CCGCCCTGCTTATCCAGT-30 (18 bp).
The relative quantiﬁcation of each gene transcript was
normalized to GAPDH and, compared with that expressed
in naïve mice. Quantitative real-time PCR using an RT2
proﬁler PCR array kit (Qiagen) was performed for groups of
genes, including Nlrp1, Nlrp3, caspase-1 (Casp1), caspase-
11 (Casp11), IL-1a (Il1a), IL-1b (Il1b), and IFN-b (Ifnb1).
cDNA samples were run on an ABI Prism 7000 sequence
detection system (Life Technologies). The expression
levels of approximately 200 genes were determined using
SA Bioscience Pathway Finder RT2 Proﬁler PCR arrays
according to the manufacturer’s recommendations (Qia-
gen). Data were collected using an ABI 7900 HT real-time
PCR system (Life Technologies). The array plate con-
tained ﬁve housekeeping genes, including Gapdh and
b-actin (Actb), and one set for genomic DNA contami-
nation as the reference genes and a control. Comparative
threshold cycle values were analyzed using the manu-
facturer’s software, and fold regulation values were
plotted. The fold regulation values were calculated byajp.amjpathol.org - The American Journal of Pathology
Figure 1 Lethal ehrlichial infection differen-
tially activates inﬂammasomes, compared with
uninfected control. A: Mice infected with the le-
thal dose of Ixodes ovatus Ehrlichia (IOE) had a
higher mRNA expression of inﬂammasome com-
ponents NLRP1, NLRP3, caspase-1, caspase-11,
IL-1a, IL-b, and cytokine IFN-a/b in liver at
different time points after infection, compared
with control. Results were normalized to house-
keeping genes and expressed as fold regulation,
compared with gene expression in naïve mice. B:
Levels of IL-1b and IL-18 increased in spleen of
lethally IOE-infected WT mice, compared with un-
infected sham controls on days 3 and 7 after
infection (p.i.). C: Levels of IL-1b and IL-18
increased in serum of lethally IOE-infected WT
mice, compared with uninfected sham controls on
day 7 p.i. D: Western blot analysis indicated higher
expression of active caspase-1 (p20) in bone
marrowederived dendritic cells (BMDCs) and bone
marrow derivedemacrophages (BMDMs), either
infected in vitro with IOE or left uninfected (con-
trol). E: Mean pixel density of Western blotting
bands for active caspase-1 was determined by
ImageJ software. Data are expressed as means 
SD. nZ 9 mice per group (AeC), pooled from two
independent experiments. Western blot results (D
and E) represent one of three independent ex-
periments with similar results. **P  0.01,
***P  0.001. Cont, control.
Type I IFN in Fatal Ehrlichiosisdividing the expression fold changes of the candidate
genes by the expression fold changes of the reference
genes using the comparative threshold cycle method.
Up-regulation or down-regulation of the host genes was
determined relative to naïve mice. Using cutoff criteria,
ﬁvefold up-regulation or down-regulation was considered
to be signiﬁcant and of biological importance.
Western Blot Analysis
Liver tissues and bone marrowederived macrophages
(BMDMs) were lysed in 1 lysis buffer (T-PER) and radi-
oimmunoprecipitation assay buffer (Thermo Fisher Scienti-
ﬁc, Waltham, MA), respectively, and debris was removed byThe American Journal of Pathology - ajp.amjpathol.orgcentrifugation. Lysates were resolved in 4% to 20% gradient
SDSePAGE gels. The protein content of the entire gel was
then transferred to a polyvinylidene diﬂuoride membrane.
The membranes were processed and probed with the
following antibodies, according to standard protocols: antie
caspase-1 (2 mg/mL) (EMD Millipore, Billerica, MA); antie
caspase-11 (5 mg/mL) (Sigma-Aldrich, St. Louis, MO);
antieIL-1b (2 mg/mL) (GeneTex, Irvine, CA); anti-LC3B
(dilution 1:2500) (Novus Biologicals, Littleton, CO); antie
beclin-1 (dilution 1:1000) (Cell Signaling Technology,
Danvers, MA); anti-FOXP3 (dilution 1:500) (Sigma-
Aldrich); and anti-GAPDH (0.2 mg/mL) (Sigma-Aldrich).
Mean pixel density of bands inWestern blots was determined
using ImageJ software version 1.48 (NIH, Bethesda, MD).449
Figure 2 Enhanced resistance of Ifnar1/ mice to lethal ehrlichiosis. A:
Survival curves for IOE-infected mice show long-term survival of Ifnar1/. B:
Bacterial burden in liver of IOE-infected mice and uninfected controls was
determined by quantitative real-time PCR on day 7 p.i. IOE-infected Ifnar1/
and Nlrp3/ mice had signiﬁcantly lower bacterial burden, compared with WT
and Casp1/ mice. Data are expressed as means  SD. n Z 12 mice per
group (A); nZ 9 mice per group, pooled from three independent experiments
(B). *P  0.05, **P  0.01.
Yang et alPreparation of Mouse BMDMs and BMDCs and Infection
with Cell-Free Ehrlichiae
BMDMs and bone marrowederived dendritic cells
(BMDCs) were propagated as described previously.37 The
BM cells were cultured in complete medium supplemented
with 200 U/mL recombinant granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) or 5  106 U/mg gran-
ulocyte colony-stimulating factor (G-CSF) (PeproTech,
Rocky Hill, NJ). Cell-free E. muris and IOE organisms were
prepared from a 90% infected macrophage cell line (DH82),
as well as from infected splenocytes harvested from the
IOE-infected mice on day 7 p.i. as described previously.6
Bacteria were added to the BMDM or BMDC cultures at
multiplicity of infection MOI Z 5. Supernatant was
collected at 12 and 24 hours after infection.
Statistical Analysis
The two-tailed t-test was used for comparison of mean
values for two experimental groups, and a one-way
analysis of variance was used for comparisons of multi-
ple experimental groups. Data are expressed as means 
SD. P  0.001 and 0.01 were considered highly signiﬁ-
cant; P  0.05 was considered moderately signiﬁcant.
Results
Inﬂammasome Activation Is Linked to the
Development of Fatal Ehrlichia-Induced Toxic Shock
The highly virulent, LPS-negative, Gram-negative IOE
strain of Ehrlichia causes lethal infection in WT C57BL/6
mice when administered at a high dose (103 bacterial
genomes per mouse) via the intraperitoneal route.5e8,45,46
We have previously demonstrated that lethal ehrlichial infec-
tion triggers excessive production of IL-18 in the liver and that
the lack of IL-18R enhances resistance of IOE-infected mice to
lethal ehrlichiosis.12 These ﬁndings suggested that inﬂamma-
some activation plays a detrimental role during infection with
LPS-negative ehrlichiae. In the present study, to determine the
molecular pathway by which ehrlichiae trigger the inﬂamma-
somes, we examined the mRNA and protein expression of
several markers of inﬂammasomes in the liver of WT mice
infected with the lethal dose of IOE. We selected the liver as
the major site of infection and pathology both clinically and in
mice infected with ehrlichiae. Our present results demonstrate
signiﬁcant up-regulation (ﬁvefold increase in gene expression,
relative to naïve mice) of mRNA expression of NLRP3,
NLRP1, caspase-1, caspase-11, IL-1b, IL-1a, and IFN-b on
days 3 and 7 p.i. (Figure 1A). Consistent with mRNA
expression, both spleen (Figure 1B) and serum (Figure 1C)
from IOE-infected mice had higher levels of IL-1b and IL-18,
compared with uninfected controls (Figure 1B). We also
examined caspase-1 activation in BMDMs and BMDCs,
which are the main target cells for ehrlichiae. Expression of450active (cleaved) caspase-1 was higher in IOE-infected
BMDMs and BMDCs from WT mice, compared with unin-
fected cells (Figure 1, D and E). These results suggest that
ehrlichiae trigger activation of the canonical inﬂammasome
pathway and up-regulate caspase-11 expression in the murine
model of fatal Ehrlichia-induced toxic shock.
Improved Survival and Protective Immunity during
Ehrlichial Infection in Ifnar1/ Mice
Recent studies have indicated that IFN-I regulate inﬂam-
masome activation during infections with intracellular
pathogens.36,42,43,47 We therefore examined IFN-I expres-
sion in a murine model of fatal ehrlichiosis. The expression
of IFN-I mRNA in the liver of IOE-infected mice was
approximately 150-fold higher than that detected in the
uninfected controls (Figure 1A). Given that IFN-I up-regu-
lation was associated with inﬂammasome activation during
fatal ehrlichial infection, we hypothesized that IFN-I pro-
motes fatal disease via activation of the inﬂammasome
pathway. To test this hypothesis, we compared the outcome
of infection in mice deﬁcient in IFNAR1, NLRP3, or
caspase-1 and infected with a high dose of IOE. We chose to
further investigate the role of NLRP3 among other inﬂam-
masomes that were up-regulated during fatal ehrlichial
infection (Figure 1A), to compare our model with other
murine models of sepsis caused by LPS-positive, Gram-ajp.amjpathol.org - The American Journal of Pathology
Figure 3 IFN-I impairs the expansion of NKT cells in liver
during fatal ehrlichial infection. A: For ﬂow cytometry, liver
mononuclear cells prepared from the liver of naïve and IOE-infected
WT,Nlrp3/, Casp1/, and Ifnar1/mice.B: Livermononuclear
cells were then analyzed for expression of TCRb and CD1d using
speciﬁc anti-TCRb monoclonal antibody and CD1d tetramer. C:
TCRbþCD1dtetþ cells were then gated and reanalyzed for B220
expression. NKT cells were deﬁned as TCRbþCD1dtetþB220 cells.
D: Absolute numbers of NKT cells in liver of naïve mice or IOE-
infected WT Nlrp3/, Casp1/, and Ifnar1/ mice were deter-
mined on day 7 p.i. Data are expressed as means  SD and are
representative of three independent experiments with similar
results. nZ 3 mice per group. **P 0.01, ***P 0.001.
Type I IFN in Fatal Ehrlichiosisnegative bacteria in which NLRP3 contributes to disease
pathogenesis. Unexpectedly, 100% of Casp1/ and
Nlrp3/ mice died of infection between days 9 and 12 p.i.,
a result similar to that of WT mice (Figure 2A). By contrast,
approximately 75% of the IOE-infected Ifnar1/ mice
survived lethal infection past day 120 p.i (Figure 2A).
Next, we examined the contribution of the IFN-I,
NLRP3 inﬂammasome, and caspase-1 in host defense
against ehrlichiae. Our results indicated that Casp1/ mice
have a higher bacterial burden in the liver than do WT mice.
Interestingly, both Ifnar1/ and Nlrp3/ mice had a lower
bacterial burden than did WT and Casp1/ mice
(Figure 2B). These results suggest that IFNAR1 and NLRP3
signaling impairs protective immunity against ehrlichiae,
independent of caspase-1 activation.
We have previously reported that protective immunity
against ehrlichiae is mediated by IFN-geproducing T cells
and natural killer T cells (NKT cells).9e11,18 However, these
cells undergo apoptosis and are functionally suppressed
during fatal ehrlichiosis.5e8,10,18 We therefore tested the
hypothesis that IFNAR1 and NLRP3 negatively regulateThe American Journal of Pathology - ajp.amjpathol.orgprotective immune responses against ehrlichiae by NKT
cells and Type I T cells. We ﬁrst measured the numbers of
NKT cells in the liver of different groups using CD1d-
aGalCer tetramers.18,48,49 Interestingly, Ifnar1/, but not
Nlrp3/, mice had signiﬁcantly increased percentages
(Figure 3, AeC) and absolute numbers (Figure 3D) of he-
patic CD1d-aGalCer tetramerepositive NKT cells (TCRbþ/
CD1dþ/B220 cells), compared with IOE-infected WT and
Casp1/ mice. These results suggest that IFNAR1, but not
NLRP3, inhibits the expansion or inﬂux of protective NKT
cells at the sites of infections during fatal ehrlichiosis.
Next, we examined T-cell responses in the experimental
groups of mice. The Ifnar1/ mice had signiﬁcantly higher
numbers of CD4þ T cells in spleen (Figure 4, A and C) and
liver (Figure 4, B and D) on day 7 p.i., compared with all
other groups of mice. In addition, Ifnar1/ mice had
signiﬁcantly higher percentages (Figure 5A) and absolute
numbers (Figure 5B) of IFN-geproducing splenic CD3þ
T cells. The increase in numbers of CD4þ T cells in IOE-
infected Ifnar1/ mice was not due to differences in
T-cell population in Ifnar1/ naïve mice; we did not451
Figure 4 Expansion of the CD4þ T-cell subset in Ifnar1/ mice after lethal IOE infection. A and B: Flow cytometry analysis of the percentage of CD4þ T
cells in spleen (A) and liver (B) of mice on day 7 p.i. with lethal Ixodes ovatus Ehrlichia infection. C and D: Absolute numbers of CD4þ T cells in spleen (C) and
liver (D) of the same mice. Data are expressed as means  SD, and are representative of three independent experiments with similar results. nZ 9 mice per
group. **P  0.01, ***P  0.001.
Yang et aldetect signiﬁcant changes in the numbers of different
T-cell subsets among naïve mice from different back-
grounds (Figure 5C). Importantly, increased frequency of
Type I T cells in Ifnar1/ mice was associated with
higher IFN-g levels, but lower IL-10 levels, in serum
(Figure 6A) and spleen (Figure 6B), and therefore a lower
IL-10/IFN-g ratio (Figure 6, A and B), compared with WT
and Casp1/ mice. Although IFN-geproducing T cells
numbers in Nlrp3/ mice did not differ signiﬁcantly,
compared with WT and Casp1/ mice, the Nlrp3/ mice
had signiﬁcantly higher levels of IFN-g and had lower IL-10/
IFN-g ratios in serum (Figure 6A) and spleen (Figure 6B),
compared with WT and Casp1/ mice. These results sug-
gest that lack of IFNAR1 and NLRP3 signaling attenuates
IL-10emediated suppressive immune responses against ehr-
lichiae, which may account for enhanced bacterial clearance
in Ifnar1/ and Nlrp3/ mice.
We next examined whether enhanced protective im-
munity and IFN-g production in Ifnar1/ and Nlrp3/
mice is due to decreased production of IL-10 by T cells,452including T regulatory cells (Tregs). Tregs are known to
suppress protective CD4þ Th1 responses during infection
with intracellular bacteria.6,7,50,51 IOE-infected Ifnar1/
mice had signiﬁcantly lower percentages (Figure 7A)
and absolute numbers of splenic IL-10eproducing
CD3þCD4þCD25þ T cells in spleen, compared with the
other groups (Figure 7, B and C).
To determine whether IFNAR1 signaling inﬂuences the
induction of Treg cells at a primary sites of infection, we
analyzed FOXP3 expression in liver tissue lysate from
all groups by Western blotting, and the frequency of
FOXP3eexpressing Treg cells in spleen by ﬂow cytom-
etry. Interestingly, liver lysate from naïve mice and
from IOE-infected WT, Nlrp3/, and Casp1/ mice
expressed FOXP3 on day 7 p.i. (Figure 7D), whereas
absence of IFNAR1 signaling abrogated hepatic FOXP3
expression in Ifnar1/ mice. Similarly, IOE-infected
Ifnar1/ mice had signiﬁcantly lower percentages and
absolute numbers of splenic CD4þFOXP3þ Tregs (mainly
those that express the CD25 marker), compared withajp.amjpathol.org - The American Journal of Pathology
Figure 5 Enhanced protective type I immune responses in IOE-infected Ifnar1/ mice. A and B: Flow cytometry analysis of the percentage (A) and
absolute number (B) of intracellular IFN-geexpressing CD3þ splenocytes from IOE-infected WT, Ifnar1/, Nlrp3/, and Casp1/ mice on day 7 p.i. C: Flow
cytometry analysis of the absolute numbers of CD3þ, CD4þ, and CD8þ T cells shows similar number of these T-cell subsets in naïve mice of different back-
grounds (WT, Ifnar1/, Nlrp3/, and Casp1/). Data are expressed as means  SD and are representative of three independent experiments (NZ 9 mice).
***P  0.001.
Type I IFN in Fatal EhrlichiosisIOE-infected WT and Casp1/ mice, (Figure 8, A
and B). Intriguingly, IOE-infected Nlrp3/ mice also
had signiﬁcantly lower numbers of splenic CD4þ
CD25þFOXP3þ Tregs and CD4þCD25FOXP3þ Tregs,
compared with WT and Casp1/ mice (Figure 8, A
and B). Taken together, these results suggest that IFNAR1
and NLRP3 promote both expansion of FOXP3þ Tregs
and production of IL-10, which may account for sup-
pressed anti-ehrlichial immunity during fatal ehrlichiosis.
Furthermore, these results show for the ﬁrst time that
IFNAR1 signaling is the major regulatory mechanism that
controls induction of Tregs in nonlymphoid peripheral
organ such as liver.
Attenuated Liver Pathology and Host Cell Death After
Ehrlichia Infection in Ifnar1/ Mice
The lack of correlation between the lower bacterial burden
and survival in Nlrp3/ mice suggested that fatal ehrlichial
infectionwas not due to an overwhelming infection, but rather
due to an immunopathology. This conclusion is consistent
with ﬁndings from our previous studies in murine models of
ehrlichiosis and in patients with human monocytotropic
ehrlichiosis. We therefore evaluated the degree of liver
damage in experimental groups of mice by hematoxylin and
eosin and TUNEL staining. Consistent with our previousThe American Journal of Pathology - ajp.amjpathol.orgﬁndings,5e11,13,14,45,46 IOE-infectedWTmice exhibited focal
areas of conﬂuent necrosis (Figure 9A) and extensive
apoptosis of both Kupffer cells and hepatocytes (Figure 9, B
and C), as well as microvesicular steatosis (Figure 9D) and
congestion on days 7 to 10 p.i. Although IOE-infected
Nlrp3/ mice were able to clear ehrlichiae, these mice had
focal areas of hepatocyte apoptosis and necrosis in the liver on
day 7 p.i., similar to that detected in the liver of IOE-infected
WT mice (Figure 9A). Casp1/mice had substantial foci of
hepatic necrosis and signiﬁcantly higher numbers of apoptotic
cells than the other groups (Figure 9, B and C). By contrast,
the severity of liver damage was signiﬁcantly attenuated in
IOE-infected Ifnar1/ mice, as indicated by a signiﬁcant
decrease in the numbers of apoptotic Kupffer cells and he-
patocytes (P< 0.01) (Figure 9, B andC). Decreased cell death
in Ifnar1/ mice was associated with more portal tract and
lobular cellular inﬁltration (predominantly lymphocytes) and
less microvesicular steatosis and congestion, compared with
WT mice (data not shown). Interestingly, IOE-infected
Ifnar1/ mice showed more evidence of hepatocyte regen-
eration,52 including binucleation of hepatocytes and extra-
medullary hematopoiesis (Figure 9E). By day 10 p.i., the
majority of WT mice had died of infection, so histological
assessment of WT mice was not feasible for this time point.
However, Ifnar1/mice were all still alive at day 10 p.i. and
exhibited perivascular granuloma-like lymphohistiocytic453
Figure 6 IFNAR1 inhibits splenic and systemic
IFN-g production while enhancing IL-10 secretion
during fatal ehrlichial infection. A: Levels of IFN-g
and IL-10 and the ratio of IL-10 to IFN-g in serum
from all infected groups of mice at day 7 p.i. B:
Levels of IFN-g and IL-10 and the IL-10/ IFN-g
ratio in culture supernatants from spleen harvested
from all infected groups of mice on day 7 p.i. Data
are expressed as means  SD and are representa-
tive of three independent experiments with similar
results. n Z 9 mice per group. *P  0.05,
**P  0.01, and ***P  0.001.
Yang et alinﬁltrates in the liver (Figure 9E), a result similar to those
previously reported in themurinemodel of mild ehrlichiosis.6
Our previous studies indicated that ehrlichiae-induced gran-
uloma formation is a marker of protective cell-mediated im-
munity against intracellular ehrlichiae.51,53 Ifnar1/ mice
also exhibited evidence of resolving liver injury (eg, less
conﬂuent necrosis) at day 10 p.i. (Figure 9F). Thus, IFNAR1
signaling promotes severe liver damage in the murine model
of fatal ehrlichiosis via a pathway that is independent of the
caspase-1 and the NLRP3 inﬂammasomes. The lack of
correlation between bacterial burden and pathology in IOE-
infected Nlrp3/ mice further suggests that fatal ehrlichio-
sis is due to immune-mediated pathology, rather than to
overwhelming infection.
IFNAR1 Regulates Noncanonical Inﬂammasome
Activation during Fatal Ehrlichia Infection
The results described above suggested that detrimental
inﬂammasome activation in the murine model of fatal
ehrlichiosis is not mediated by caspase-1 (the canonical
inﬂammasome pathway). The activation of caspase-11 via
the noncanonical inﬂammasome pathway mediates in-
ﬂammatory host-cell death and secretion of IL-1b.54e56
We hypothesized that IFN-I mediates the activation of
caspase-11 and triggers the noncanonical inﬂammasome
pathway, causing excessive inﬂammation and tissue injury
after lethal ehrlichial infection. To test our hypothesis, we
ﬁrst measured IL-1b secretion in all groups of mice.
Compared with WT and Casp1/ mice, the level of the
biologically active form of IL-1b (17 kDa) was signiﬁ-
cantly decreased in liver lysate (Figure 10A) and serum454(Figure 10B) from Ifnar1/ and Nlrp3/ mice on day 7
p.i. Surprisingly, Casp1/ mice still produced signiﬁcant
levels of IL-1b in liver and serum, compared with unin-
fected controls (Figure 10, A and B). These results suggest
that IL-1b secretion in the murine model of fatal ehrlichi-
osis is dependent on IFNAR1, and partially dependent on
NLRP3, but independent of caspase-1.
Next, we measured the expression of active caspase-11 in
liver lysate of IOE-infected mice on day 7 p.i. Active
caspase-11 was highly expressed in the liver of WT and
Casp1/ mice, whereas it was partially decreased in the
liver lysate from Nlrp3/ mice. By contrast, expression of
active caspase-11 in the liver of Ifnar1/ was completely
abrogated (Figure 10A). These results suggest that ehrli-
chiae induce activation of the noncanonical inﬂammasome
pathway in vivo, which is completely dependent on IFNAR1
and is mediated in part by NLRP3 signaling. In vitro results
also showed that expression of proecaspase-11 and active
caspase-11 in BMDMs is dependent on IFNAR1, as evi-
denced by decreased expression of proecaspase-11 in
IOE-infected BMDMs from Ifnar1/ mice, compared
with WT mice (Figure 10, C and D). Of note, we did not
detect cleavage and activation of caspase-11 in IOE-
infected WT or Ifnar1/ BMDMs (data not shown),
suggesting that in vitro IOE-infected BMDMs lack danger
signaling mechanisms that promote activation and cleav-
age of caspase-11. In accord with other reports, we did not
detect expression of proecaspase-11 or active caspase-11
in uninfected or IOE-infected BMDMs or BMDCs from
Casp1/ mice (data not shown). Surprisingly, active
caspase-11 was also expressed in liver lysate from
IOE-infected Casp1/ mice (Figure 10A). These resultsajp.amjpathol.org - The American Journal of Pathology
Figure 7 IFNAR1 signaling increased the numbers of IL-10eproducing-CD3þCD4þCD25þ T cells and the number of FOXP3-expressing Tregs in liver during
fatal ehrlichial infection. A: Flow cytometry analysis of the percentage of CD3þCD4þCD25þ and IL-10þCD3þCD4þCD25þ T cells in spleen at day 7 p.i. B and C:
Absolute number of CD3þCD4þCD25þ T cells (B) and IL-10þCD3þCD4þCD25þ T cells (C) in spleen at day 7 p.i. D: FOXP3 protein expression in liver was
determined via Western blot analysis of liver lysate. Data are expressed as means  SD and are representative of three independent experiments with similar
results. n Z 9 mice per group. *P  0.05, **P  0.01.
Type I IFN in Fatal Ehrlichiosissuggest that caspase-11 expression and activation is
induced in the liver of Casp1/ mice on ehrlichial
infection.
Ehrlichiae Block Autophagy Processing That Is
Dependent on IFNAR1
Previous studies have shown that inhibition of inﬂammasome
activation after infection with LPS-positive, Gram-negative
bacteria augments the autophagy ﬂux.33,57e66 Autophagy is
also an important host defense mechanism that mediates
clearance of intracellular bacteria. We therefore hypothesized
that IFNAR1 mediates inﬂammmasome activation in
IOE-infected WT and other susceptible mice (Casp1/ and
Nlrp3/), which in turn inhibits the autophagocytic response
to ehrlichiae. To test this hypothesis, we examined the dif-
ference in autophagosome processing marked by LC3 in all
groups of mice. Two forms of LC3 (ie, LC3I and LC3II) are
produced post-translationally. LC3I is cytosolic, whereas
LC3II is membrane bound and exhibits enrichment on the
autophagosome vacuoles.19,67 The LC3 processing indicated
by a higher LC3II/LC3I ratio suggests effective autophagy
ﬂux whereby the autophagosome fuses with the lysosome,
leading to the degradation of intracellular bacteria. Our results
demonstrated that the high susceptibility of IOE-infectedWT
and Casp1/ mice is associated with equal expression ofThe American Journal of Pathology - ajp.amjpathol.orgboth LC3I and LC3II in liver lysate (Figure 11, A and B),
which suggests defective autophagosome processing. By
contrast, liver lysate from IOE-infected Ifnar1/ and
Nlrp3/ mice had three- and fourfold higher expression of
LC3II than LC3I, respectively, which suggests LC3 pro-
cessing (Figure 11, A and B). However, the level of both
forms of LC3 was lower in IOE-infected Ifnar1/mice than
in the other groups ofmice. Because Ifnar1/micewere able
to effectively clear ehrlichiae, we postulated that low levels of
LC3II could be due to enhanced autophagy ﬂux and binding
of the autophagosome to the lysosome.
To further determine whether the lack of LC3 processing is
coupled with defective induction of the autophagosome in
IOE-infected WT and Casp1/ mice, compared with
Nlrp3/ and Ifnar1/ mice, we examined beclin-1
expression in liver lysate. Beclin-1 is an important protein
that mediates autophagy initiation and nucleation, and its
function is thought to be controlled by cleavage.58,68 TheWT
mice and all knockout mice expressed similar levels of full-
length beclin-1 in the liver tissues on day 7 p.i. (Figure 11, A
and C). However, cleaved beclin-1 was detected in liver
lysate of IOE-infected WT, Casp1/, and Nlrp3/ mice,
but not Ifnar1/ mice (Figure 11, A and C). Studies have
indicated that cleaved beclin-1 fails to induce autophagy but
can associate with mitochondria to induce apoptosis.68,69 In
conclusion, the correlation between ineffective bacterial455
Figure 8 IFNAR1 signaling promotes expansion of FOXP3þ Treg cells in spleen during fatal ehrlichial infection. A: Flow cytometry analysis of the per-
centage of CD3þCD4þCD25þFOXP3þ Tregs. B and C: Absolute number of CD4þCD25þFOXP3þ (B) and of CD3þCD4þCD25FOXP3þ (C) Tregs in spleen of the
different groups, including uninfected control, at day 7 p.i. Data are expressed as means  SD and are representative of two independent experiments with
similar results. n Z 9 mice per group. *P  0.05, **P  0.01, and ***P  0.001.
Yang et alclearance in WT and Casp1/ mice, compared with
Nlrp3/ and Ifnar1/ mice, suggests that autophagy is
blocked during fatal ehrlichial infection via a pathway that
is dependent on NLRP3 and IFNAR1 signaling.Discussion
We have previously demonstrated that inﬂammasome
activation plays a detrimental role in the pathogenesis of
Ehrlichia-induced toxic shock.12 With the present study,
we have demonstrated that IFNAR1 contributes to
caspase-11emediated, noncanonical inﬂammasome acti-
vation and the subsequent secretion of the caspase-
1edependent cytokine IL-1b, thus promoting host
susceptibility to fatal ehrlichial infection. In addition, our
results suggest that NLRP3 and caspase-1 are involved in
the secretion of IL-1b and inﬂammasome activation in
response to ehrlichiae, although these pathways play a
minor role in host susceptibility to fatal ehrlichial infec-
tion. A recent study has indicated that IFN-I promotes456severe disease in the murine model of fatal ehrlichiosis,43
although a clear mechanism has not been identiﬁed. Our
results indicate that IFNAR1 impairs protective immunity
while enhancing host-cell death and immunopathology,
and that both mechanisms are essential determinants of
disease progression and the development of multiorgan
failure after fatal ehrlichial infection.
We and others have demonstrated that the effective
clearance of ehrlichiae is mediated by the balance between
the protective responses mediated by IFN-g, NKT cells and
CD4þ Th1 cells and the suppressive responses mediated by
the IL-10 and IL-10eproducing CD4þ T cells.7e12 IL-10
inhibits intracellular bacterial elimination via the suppres-
sion of IFN-geproducing T cells and bactericidal functions
of phagocytic cells.45,46 Consistent with our previous
results, in the present study responses in the murine model
of fatal ehrlichiosis were biased toward a weak NKT-cell
response and a suppressive T-cell phenotype. By contrast,
the lack of IFNAR1 restored the protective phenotype. More
importantly, the lack of IFNAR1 abrogated local and sys-
temic IL-10 production and expansion of IL-10eproducingajp.amjpathol.org - The American Journal of Pathology
Figure 9 IOE-infected Ifnar1/ mice have altered hepatic pathology, with increased cellular inﬁltration and less apoptosis, compared with WT mice. A
and B: Livers were harvested on day 7 p.i., and liver sections were stained by hematoxylin and eosin (H&E) (A) or by TUNEL (B). C: Tunel assay revealed
signiﬁcantly lower numbers of apoptotic Kupffer cells (gray bars, P < 0.01) and hepatocytes (black bars, P < 0.01) in IFNaR1/ mice, compared with WT and
casp1/ mice. The number of apoptotic Kupffer cells, but not hepatocytes, in NLRP3/ mice was also signiﬁcantly lower than that detected in WT and
casp1/ mice. The number of apoptotic cells was counted within 10 high-power ﬁelds (40 magniﬁcation). D: Liver from IOE-infected WT mice, but not
Ifnar1/ mice, exhibited microvesicular steatosis. E: Compared with the other groups, liver of IOE-infected Ifnar1/ mice had more inﬂammatory cell
inﬁltration (composed primarily of lymphocytes) and pronounced regenerative changes, including extramedullary hematopoiesis with aggregates of eryth-
rocyte precursors observed within sinusoids. F: By day 10 p.i., when most WT mice had died of infection, Ifnar1/ mice exhibited prominent perivascular
granuloma-like lymphohistiocytic inﬁltrates. Data are expressed as means  SD and are representative of three independent experiments with similar results.
n Z 9 mice per group. *P  0.05, **P  0.01. Original magniﬁcation, 40. HPF, high-power ﬁeld.
Type I IFN in Fatal EhrlichiosisCD4þ T cells and FOXP3þCD25þ Tregs at secondary
lymphoid organs (spleen), as well as FOXP3þ Tregs at
peripheral sites of infection (liver) (Figures 7D and 8,
AeC), which restores the protective Th1 response against
ehrlichiae. These intriguing results show a correlation
between the immune regulatory responses in peripheral
organs (liver) and secondary lymphoid organs (spleen). In
addition, our results reveal for the ﬁrst time that activation
of IFN-I is the major mechanism that accounts for induction
and/or expansion of FOXP3þ Tregs at the site of infection
and is responsible for suppression of protective immunity
during infection with these obligate intracellular bacteria.
Our present results explain the recent ﬁnding that IFN-g
neutralization in IOE-infected Ifnar1/ mice fails to revert
the protective immune phenotype observed in these
knockout mice.43 Decreased IL-10 production, decreasedThe American Journal of Pathology - ajp.amjpathol.orgfrequency of FOXP3þ Tregs at lymphoid and peripheral
organs, and increased expansion of NKT cells observed in
IOE-infected Ifnar1/ mice are the likely factors that
provide optimal host defense and protective immunity in our
model. In support of this conclusion, in the present study
IOE-infected Nlrp3/ mice were able to clear infection
similar to Ifnar1/ mice, even though neither IFN-g pro-
duction nor IFN-geproducing cell numbers increased in the
absence of NLRP3 signaling. However, effective bacterial
clearance in Nlrp3/ mice correlated with decreased pro-
duction of IL-10 and decreased numbers of FOXP3þCD25þ
Tregs in spleen, which may account for enhanced bacterial
clearance in these mice.
Our results also suggest that the enhanced intracellular
bacterial elimination in Nlrp3/ and Ifnar1/ could be
mediated also by effective autophagy ﬂux (Figure 11).457
Figure 11 IFN-I blocks degradation of autophagy during fatal ehrli-
chial infection. Liver lysate from the different groups of mice was analyzed
for expression of autophagy markers LC3I and LC3II (A and B) and beclin-1
(A and C) by Western blotting on day 7 p.i. GAPDH expression was used as
loading control. Band density was quantiﬁed using ImageJ software and
was normalized to GAPDH. Results are from one mouse in each group and
are representative of three independent experiments with similar results.
n Z 3 mice per group.
Figure 10 IFNAR1 regulates IL-1b secretion during fatal ehrlichial
infection. A: Liver lysate from the different groups of mice was analyzed for
expression of IL-1b (p17) and active caspase-11 (p30) by Western blotting
on day 7 p.i. GAPDH expression was used as loading control. B: Serum levels
of IL-1b were measured using enzyme-linked immunosorbent assay on day 7
p.i. C and D: BMDMs from IOE-infected WT and Ifnar1/ mice express
proecaspase-11 (p45). Expression of proecaspase-11 was normalized to
GAPDH. Results in A, C, and D are from one mouse in each group and are
representative of three independent experiments with similar results (nZ 9
mice per group). Data in B are expressed as means  SD and are repre-
sentative of three independent experiments with similar results (nZ 9 mice
per group). *P  0.05.
Yang et alDefective LC3 processing and beclin-1 cleavage fail to clear
ehrlichiae in WT and Casp1/ mice, in contrast to Ifnar1/
and Nlrp3/ mice (Figure 11). These results suggest that
autophagy ﬂux is blocked in the murine model of fatal ehr-
lichiosis via an IFNAR1-dependent mechanism. How
IFNAR1 blocks autophagy during ehrlichiosis is not yet
known. Several studies have demonstrated a causal relation-
ship between activation of inﬂammasomes and defective
autophagy process. In the present study, the correlation
between decreased IL-1b secretion, lack of caspase-1 acti-
vation, effective bacterial clearance, and enhanced autophagy
ﬂux suggest a similar mechanism in fatal ehrlichiosis. This
raises the question of whether autophagy occurs upstream or
downstream of inﬂammasome activation. A recent study458suggested that, during infection with Gram-negative bacteria,
autophagy ﬂux occurs as a countermeasure to reduce exces-
sive caspase-11 activation by cytosolic LPS.47 We argue,
however, that the Ehrlichia-induced block in autophagy
processing in WT host occurs upstream of noncanonical
inﬂammasome activation. This conclusion is supported by
several ﬁndings. First, our kinetic studies have demonstrated
that ineffective elimination of ehrlichiae by innate response
precedes the excessive inﬂammasome activation and pro-
duction of inﬂammatory cytokines.5e7,9e11,45,46 Second, a
recent study demonstrated that Anaplasma phagocytophilum,
obligate intracellular bacteria closely related to ehrlichiae,
secrete a type IV effector (ATs-1) that hijacks the beclin-1
autophagy pathway as an immune evasion and early sur-
vival mechanism.58 Although a similar mechanism has not
yet been identiﬁed in ehrlichiae, cleavage of beclin-1 in
ehrlichia-infected WT mice may be due to binding of secreted
molecule or molecules to beclin-1 at an early stage of
infection, causing defective autophagy (Figure 11). This
in turn would lead to failure to clear microbial and host
danger signals (pathogen-associated and damage-
associated molecular patterns, known as PAMPs and
DAMPs) that trigger inﬂammasome activation.ajp.amjpathol.org - The American Journal of Pathology
Type I IFN in Fatal EhrlichiosisImmunopathology, marked by host-cell apoptosis and
hepatic microvesicular steatosis, is a major mechanism
responsible for multiorgan failure during lethal ehrlichial
infection in mice (Figure 9, A and B) and humans.13,14,21,26,70
Both the correlation between the attenuation of pathology and
host-cell death and the resistance to fatal ehrlichiosis in
Ifnar1/ mice and the lack of correlation between effective
bacterial elimination and survival in Nlrp3/ mice strongly
support the conclusion that fatal ehrlichiosis is due mainly to
excessive immunopathology. Activation of caspase-11 is
known to trigger inﬂammatory host-cell death (ie, pyropto-
sis)36,71,72 associated with secretion of IL-1a and IL-1b, both
of which are detected in fatal ehrlichial infection (Figure 1).
Abrogation of caspase-11 activation in IOE-infected Ifnar1/
mice (Figure 10) suggests that IFNAR1 induces host-cell
death during fatal ehrlichial infection via activation of the
caspase-11edependent noncanonical inﬂammasome pathway.
Finally, our results demonstrate that caspase-1 is dispens-
able for toxic shock caused by LPS-negative ehrlichiae inde-
pendent of IL-1b production. The presence of overwhelming
infection, extensive host-cell death, and incomplete attenuation
of IL-1b secretion in IOE-infected Casp1/ mice, compared
with WT mice, suggests that other caspases may promote
detrimental inﬂammasome activation. Caspase-8 has been
demonstrated to assemble a multimeric protein complex in
response to bacterial infection and to induce proeIL-1b pro-
cessing in host cells infected with pathogenic bacteria, distinct
from the NLRP3ecaspase-1 inﬂammasome pathway.73 Other
studies have indicated that caspase-11 expression increases
susceptibility to Salmonella species infection in the absence of
caspase-155. We therefore speculate that the expression of
caspase-8- or caspase-11emediated processing of IL-1b and
cell death in Casp1/ mice is more apparent in the absence of
caspase-1 and may account for heightened host susceptibility
to fatal ehrlichial infection. The exact mechanism that accounts
for the difference between our results and those described in
sepsis models caused by other bacteria or acute lung injury
caused by LPS injection is not yet known. However, because
ehrlichiae lack LPS, we argue that Ehrlichia-induced IFN-1
response and inﬂammasome activation involve signaling by
other pathogen-associated molecular patterns. For example,
ehrlichiae express type IV and type I secretion systems,4
through which several bacterial effector molecules [eg, tan-
dem repeat protein 47 (TRP47), TRP120, TRP32, and the
ankyrin repeat protein Ank200)] are secreted into the cytosol
and extracellular milieu. These effectors are involved in
several molecular hostepathogen interactions, including DNA
binding and signaling events that lead to immune evasion,
transcriptional regulation, actin nucleation, bacterial dissemi-
nation, and apoptosis.4 Thus, these bacterial effector molecules
may be major ligands that trigger inﬂammasome activation
and IFN-1 responses in fatal ehrlichiosis, a possibility to be
explored in future studies.
In summary, the present study establishes, for the ﬁrst
time, that IFN-I is the master regulator of the observed
detrimental innate and acquired immune responses duringThe American Journal of Pathology - ajp.amjpathol.orginfection with ehrlichiae, which are obligate intracellular
bacteria that lack LPS. Critical mechanisms include the
blocking of autophagy and the activation of the caspase-
11edependent noncanonical inﬂammasome pathway. By
engaging caspase-11 and blocking LC3 maturation, ehrli-
chiae trigger host-cell death, enhance bacterial replication,
and induce assembly of the NLRP3 inﬂammasome or of
other as yet unidentiﬁed inﬂammasomes to activate caspase-1
activation, which (in part) mediates IL-1b/IL-18 secretion. As
we have recently reported,12 IL-18 and host-cell death induce
pathogenic-acquired immune responses and bias the anti-
ehrlichial T-cell responses toward the suppressive pheno-
type. The present results have important clinical implications
and could help lead to design of novel immunotherapeutic
agents that target IFN-I and/or caspase-11 pathways and thus
inhibit development of dysregulated inﬂammation and
immunopathology while promoting protective immunity
against ehrlichiae or similar Gram-negative bacteria.
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